Polycystic ovary syndromeThe effects of metformin with lifestyle therapy in polycystic ovary syndrome: a randomized double-blind study
Presented in part at the 92nd Annual Meeting of the Endocrine Society, San Diego, California, June 18–22, 2010.
Under an Elsevier user license
open archive
Key Words
Ovarian function
insulin action
nutrition
exercise
androgen
Cited by (0)
Trial Registration: Clinicaltrials.gov identification no. NCT00151411.
A.R.K. reports ownership of Merck stock. R.S.L. reports a paid lecture fee from Serono. G.L. has nothing to disclose. W.C.D. has nothing to disclose. S.D.S. has nothing to disclose. A.E.A. has nothing to disclose. L.M.D. has nothing to disclose. N.I.W. has nothing to disclose. P.C. has nothing to disclose.
Supported by grant no. PHS U54 HD044315 from the Meharry Medical College/Penn State Cooperative Reproductive Science Center and by grant no. MO1 RR 10732 and construction grant no. C06 RR016499 to Pennsylvania State University from the General Clinical Research Center.
Copyright © 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.